Qingfei Paidu decoction(QFPDD)has been extensively used in clinical treatments during the severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)epidemic.SARS-CoV-2 primarily invades host cells via its spike(S)pro...Qingfei Paidu decoction(QFPDD)has been extensively used in clinical treatments during the severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)epidemic.SARS-CoV-2 primarily invades host cells via its spike(S)protein binding to the angiotensin-converting enzyme 2(ACE2)on the cell membrane,mediating viral-host membrane fusion.Blocking viral entry is a crucial step in preventing infection,with the interaction between the S receptor binding domain(S-RBD)and ACE2 being a key antiviral target.Given that SARS-CoV-2 predominantly affects the respiratory system and approxi-mately 25%of patients suffering from corona virus disease 2019(COVID-19)with gastrointestinal symptoms,we are com-mitted to identifying more active ingredients in QFPDD that target the respiratory and gastrointestinal tracts of COVID-19 patients.Among medicinal plants,ephedra and liquorice derived from QFPDD,along with two other Chinese herbs,Platycodon grandiflorum and Radix Rhei Et Rhizome(rhubarb),have garnered our interest.These herbs have historically been used in traditional Chinese medicine(TCM)for treating infectious diseases with respiratory and digestive symp-toms.Here,we established a library containing all components of the four individual herbs gathered from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform(TCMSP)and performed structure-based virtual screening to identify potential ACE2/S-RBD inhibitors.Subsequently,we selected 10 ingredients from the top 30 candidates and evaluated their activities using a pseudovirus neutralization assay.Delphinidin and deapio platyco-din D(DPD)showed significant antiviral potential with half-maximal inhibitory concentration(IC_(50))values of 45.35 μM and 1.38 μM,respectively.Furthermore,delphinidin also inhibited the 3-chymotrypsin-like protease(3CL^(pro)),indicating its dual-viral target inhibitory potential.Notably,DPD effectively suppressed HCoV-229E replication in BEL-7402 cells.This study not only provides a strategy for rapid identifying antiviral agents from TCM in anticipation of future pandemics but also offers theoretical and experimental evidence to support for the clinical use of QFPDD.展开更多
基金supported by the Shanghai Municipal Science and Technology Major Project(ZD2021CY001)the Shanghai Oriental Talent Program for Top-notch Project(No.BJWS2024068)+2 种基金the National Key Research and Development Program of China(2023YFC3503400,2022YFC3502000)the SIMM-SHUTCM Traditional Chinese Medicine Innovation Joint Research Program(E2G805H)the National Natural Science Foundation of China(82141203).
文摘Qingfei Paidu decoction(QFPDD)has been extensively used in clinical treatments during the severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)epidemic.SARS-CoV-2 primarily invades host cells via its spike(S)protein binding to the angiotensin-converting enzyme 2(ACE2)on the cell membrane,mediating viral-host membrane fusion.Blocking viral entry is a crucial step in preventing infection,with the interaction between the S receptor binding domain(S-RBD)and ACE2 being a key antiviral target.Given that SARS-CoV-2 predominantly affects the respiratory system and approxi-mately 25%of patients suffering from corona virus disease 2019(COVID-19)with gastrointestinal symptoms,we are com-mitted to identifying more active ingredients in QFPDD that target the respiratory and gastrointestinal tracts of COVID-19 patients.Among medicinal plants,ephedra and liquorice derived from QFPDD,along with two other Chinese herbs,Platycodon grandiflorum and Radix Rhei Et Rhizome(rhubarb),have garnered our interest.These herbs have historically been used in traditional Chinese medicine(TCM)for treating infectious diseases with respiratory and digestive symp-toms.Here,we established a library containing all components of the four individual herbs gathered from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform(TCMSP)and performed structure-based virtual screening to identify potential ACE2/S-RBD inhibitors.Subsequently,we selected 10 ingredients from the top 30 candidates and evaluated their activities using a pseudovirus neutralization assay.Delphinidin and deapio platyco-din D(DPD)showed significant antiviral potential with half-maximal inhibitory concentration(IC_(50))values of 45.35 μM and 1.38 μM,respectively.Furthermore,delphinidin also inhibited the 3-chymotrypsin-like protease(3CL^(pro)),indicating its dual-viral target inhibitory potential.Notably,DPD effectively suppressed HCoV-229E replication in BEL-7402 cells.This study not only provides a strategy for rapid identifying antiviral agents from TCM in anticipation of future pandemics but also offers theoretical and experimental evidence to support for the clinical use of QFPDD.
